M Toi Selected Research

Time-to-Treatment

6/2017

Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Toi Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2000
40	Neoplasms (Cancer) 12/2022 - 01/2000
7	Neoplasm Metastasis (Metastasis) 04/2009 - 01/2000
6	Carcinoma (Carcinomatosis) 07/2005 - 04/2001
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2005 - 05/2001
3	Disease Progression 05/2024 - 01/2001
2	Residual Neoplasm 01/2017 - 08/2000
2	Pain (Aches) 09/2012 - 04/2001
2	Adenocarcinoma 07/2005 - 04/2001
2	Carcinoid Tumor (Carcinoid) 01/2005 - 04/2001
2	Fibrosis (Cirrhosis) 01/2005 - 01/2000
2	Oxyphilic Adenoma (Oncocytoma) 12/2001 - 10/2001
2	Hepatocellular Carcinoma (Hepatoma) 07/2001 - 07/2000
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2001 - 07/2000
1	Cytopenia 01/2022
1	Febrile Neutropenia 12/2017
1	Triple Negative Breast Neoplasms 04/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Margins of Excision 08/2016
1	Colorectal Neoplasms (Colorectal Cancer) 11/2011
1	Hand-Foot Syndrome 11/2011
1	Erythema 11/2011
1	Brain Neoplasms (Brain Tumor) 11/2009
1	Breast Carcinoma In Situ 01/2009
1	Hyperplasia 01/2009
1	Neutropenia 05/2008
1	Peptic Ulcer (Peptic Ulcers) 01/2006
1	Endometrial Neoplasms (Endometrial Cancer) 10/2005

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 12/2022 - 07/2000
9	Docetaxel (Taxotere)FDA Link 12/2017 - 06/2001
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006 - 08/2000
6	Trastuzumab (Herceptin)FDA Link 07/2018 - 01/2001
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 06/2004
6	EnzymesIBA 10/2005 - 01/2000
6	Proteins (Proteins, Gene)FDA Link 02/2005 - 07/2000
5	Aromatase InhibitorsIBA 05/2024 - 01/2000
5	Epirubicin (Ellence)FDA LinkGeneric 08/2014 - 06/2004
5	Capecitabine (Xeloda)FDA Link 08/2014 - 04/2000
5	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2006 - 10/2002
5	Thymidine PhosphorylaseIBA 06/2004 - 07/2000
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2018 - 12/2001
4	Lapatinib (GW572016)FDA Link 07/2018 - 11/2009
4	Fluorouracil (Carac)FDA LinkGeneric 08/2014 - 06/2004
4	Messenger RNA (mRNA)IBA 01/2005 - 05/2000
3	abemaciclibIBA 05/2024 - 12/2021
3	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2001
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 04/2001
3	Tamoxifen FDA LinkGeneric 01/2009 - 01/2001
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2006 - 10/2005
3	Keratins (Keratin)IBA 01/2006 - 01/2004
3	Celecoxib (Celebrex)FDA Link 10/2005 - 10/2005
3	Estrogen ReceptorsIBA 07/2005 - 01/2000
3	Capsules (Microcapsules)IBA 01/2005 - 12/2002
3	beta CateninIBA 05/2001 - 11/2000
2	Fulvestrant (Faslodex)FDA Link 05/2024 - 06/2017
2	Bevacizumab (Avastin)FDA Link 04/2017 - 11/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2006 - 10/2005
2	Carcinoembryonic AntigenIBA 07/2005 - 04/2001
2	Indicators and Reagents (Reagents)IBA 01/2004 - 08/2000
2	ImmunosorbentsIBA 04/2003 - 07/2000
2	Monoclonal AntibodiesIBA 05/2002 - 01/2001
2	DNA (Deoxyribonucleic Acid)IBA 07/2001 - 04/2001
2	VimentinIBA 04/2001 - 05/2000
2	OsteonectinIBA 04/2001 - 05/2000
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2001 - 05/2000
2	EndostatinsIBA 03/2001 - 01/2001
2	Estrogen Receptor alphaIBA 02/2001 - 05/2000
2	CytokinesIBA 08/2000 - 01/2000
2	Interleukin-4 (Interleukin 4)IBA 08/2000 - 01/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2000 - 01/2000
1	Poly Adenosine Diphosphate RiboseIBA 12/2022
1	olaparibIBA 12/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	HLA-DRB1*07 antigenIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	Everolimus FDA Link 01/2016
1	Dihydrotachysterol (AT 10)IBA 09/2012
1	Phenobarbital (Luminal)FDA Link 07/2012
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2009
1	pegfilgrastim (Neulasta)FDA Link 05/2008
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2006
1	CAM 5.2 antigenIBA 01/2006
1	K-18 conjugate (K18)IBA 10/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2005
1	exemestane (Aromasin)FDA Link 10/2005
1	LipidsIBA 10/2005

Therapy/Procedure

29	Therapeutics 05/2024 - 01/2000
10	Drug Therapy (Chemotherapy) 07/2018 - 04/2001
7	Neoadjuvant Therapy 07/2018 - 01/2001
1	Time-to-Treatment 06/2017
1	Adjuvant Chemotherapy 04/2017
1	Segmental Mastectomy (Lumpectomy) 08/2016
1	Premedication 11/2011
1	Metastasectomy 04/2009
1	Chemoprevention 01/2009
1	Transplantation 10/2005